Skip to main content
SpringerLink
Log in

Cardiac toxicity with trastuzumab: acceptable and reversible?

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Guarneri V, Lenihan DJ, Valero V, Durand J-B, Broglio K, Hess KR, Michaud LB, Gonzalez-Angulo AM, Hortobagyi GN, Esteva FJ.Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience. Journal of Clinical Oncology 24: 4107-4115, No. 25, 1 Sep 2006

  2. Hayes DF.Heart of darkness: the downside of trastuzumab. Journal of Clinical Oncology 24: 4056-4058, No. 25, 1 Sep 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cardiac toxicity with trastuzumab: acceptable and reversible?. React. Wkly. 1116, 1 (2006). https://doi.org/10.2165/00128415-200611160-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200611160-00001

Keywords

Search

Navigation